The Community has adopted and published a regulation - Regulation 816/2006 - on compulsory licensing of patents relating to the manufacture of pharmaceutical products for export to countries with health problems.
This regulation sets up, within the EC, the system that had been foreseen in paragraph 6 of the Decision of the General Council of the WTO of August 30th, 2003 implementing the Doha Declaration on the TRIPS Agreement and public health. It enters into force at the end of June 2006.
The regulation that the Community has adopted for pharmaceutical products for export to countries with health problems is a great idea. All pharmacy drugs need help to do good to people.
Posted by: Andrea | August 03, 2007 at 01:16 AM